Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture
- 30 September 2007
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 51 (2-4) , 237-244
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Normal Biogenesis and Cycling of Empty Synaptic Vesicles in Dopamine Neurons of Vesicular Monoamine Transporter 2 Knockout MiceMolecular Biology of the Cell, 2005
- The Dopamine Transporter Constitutively Internalizes and Recycles in a Protein Kinase C-regulated Manner in Stably Transfected PC12 Cell LinesJournal of Biological Chemistry, 2003
- Increased Methamphetamine Neurotoxicity in Heterozygous Vesicular Monoamine Transporter 2 Knock-Out MiceJournal of Neuroscience, 1999
- Increased MPTP Neurotoxicity in Vesicular Monoamine Transporter 2 Heterozygote Knockout MiceJournal of Neurochemistry, 1998
- Vesicular Transport Regulates Monoamine Storage and Release but Is Not Essential for Amphetamine ActionNeuron, 1997
- Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporterNature, 1996
- Functional Identification and Molecular Cloning of a Human Brain Vesicle Monoamine TransporterJournal of Neurochemistry, 1993
- Expression cloning of a reserpine-sensitive vesicular monoamine transporter.Proceedings of the National Academy of Sciences, 1992
- Selective dopamine transporter inhibition by cocaine analogsNeuroReport, 1992
- A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporterCell, 1992